Nezha delivered 11009 cars in January

Chassis Supply Chain's "iPhone Moment": China's Tier 1 Shift as LeeKr Emerges

Over the past decade, China's electric vehicle (EV) industry has evolved from a niche experiment into a leading force in the global automotive landscape. In the first ten months of 2025, China exported over 2 million EVs, nearly double the year-earlier figure. From European city streets to Southeast Asian highways and Latin American urban centers, Chinese EVs have emerged as one of the most prominent symbols of a new era of “Made in China.”

Chinese technology enterprise HONOR (荣耀) robot "Lightning" wins Yizhuang Half Marathon, setting human world record at 50:26

On April 19, the 2026 Beijing Yizhuang Humanoid Robot Half Marathon concluded with a historic victory. The humanoid robot "Lightning" (闪电), developed by the HONOR Qitian Dasheng Team (荣耀齐天大圣队), secured the championship with a net time of 50 minutes and 26 seconds.

MITI Responds to Chinese EV Leader BYD (比亚迪) Factory Controversy: Insisting on Export-Oriented Models to Protect Domestic Auto Industry

On April 17, Sim Tze Tzin, Deputy Minister of Investment, Trade, and Industry (MITI) of Malaysia, responded to rumors regarding potential changes to BYD’s plan to build a factory in Tanjung Malim, Perak.

Unpacking China | Key Chinese Firms to Watch This Week （12/04/2026-17/04/2026）

Amid fast-paced changes that fill the business community with excitement, angst and trepidation, EqualOcean will publish a series of roundup articles to document the major events related to Chinese companies going global every week.

Chinese EV leader BYD (比亚迪) South Africa avoids price war, focusing on long-term brand value via differentiation

On April 15, Steve Chang, Managing Director of BYD South Africa, stated at the launch of the ATTO 8 in Johannesburg that the company will firmly avoid frequent price cuts despite intensifying competition. While many new Chinese NEV entrants are relying on deep launch discounts to gain market share, BYD is pursuing a more patient brand-building path centered on "price parity."